DK1206256T3 - Kombinationsbehandling under anvendelse af pentafluorbenzensulfonamid og platinforbindelse - Google Patents

Kombinationsbehandling under anvendelse af pentafluorbenzensulfonamid og platinforbindelse

Info

Publication number
DK1206256T3
DK1206256T3 DK00953755T DK00953755T DK1206256T3 DK 1206256 T3 DK1206256 T3 DK 1206256T3 DK 00953755 T DK00953755 T DK 00953755T DK 00953755 T DK00953755 T DK 00953755T DK 1206256 T3 DK1206256 T3 DK 1206256T3
Authority
DK
Denmark
Prior art keywords
combination treatment
platinum compound
pentafluorobenzene
sulfonamide
pentafluorobenzene sulfonamide
Prior art date
Application number
DK00953755T
Other languages
English (en)
Inventor
Susan Schwendner
Pieter Timmermans
Jacqueline Walling
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK1206256T3 publication Critical patent/DK1206256T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Weting (AREA)
DK00953755T 1999-07-29 2000-07-27 Kombinationsbehandling under anvendelse af pentafluorbenzensulfonamid og platinforbindelse DK1206256T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14643699P 1999-07-29 1999-07-29
PCT/US2000/020763 WO2001008693A2 (en) 1999-07-29 2000-07-27 Combination therapy using pentafluorobenzenesulfonamide and platin compound

Publications (1)

Publication Number Publication Date
DK1206256T3 true DK1206256T3 (da) 2005-08-15

Family

ID=22517356

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00953755T DK1206256T3 (da) 1999-07-29 2000-07-27 Kombinationsbehandling under anvendelse af pentafluorbenzensulfonamid og platinforbindelse

Country Status (16)

Country Link
US (1) US6355628B1 (da)
EP (1) EP1206256B8 (da)
JP (1) JP2003505513A (da)
KR (1) KR100685059B1 (da)
CN (1) CN1181819C (da)
AT (1) ATE294574T1 (da)
AU (1) AU775305B2 (da)
CA (1) CA2380078C (da)
DE (1) DE60019937T2 (da)
DK (1) DK1206256T3 (da)
ES (1) ES2241639T3 (da)
IL (2) IL147890A0 (da)
PT (1) PT1206256E (da)
RU (1) RU2268054C2 (da)
WO (1) WO2001008693A2 (da)
ZA (1) ZA200200889B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0896533T3 (da) * 1996-02-22 2004-01-26 Tularik Inc Pentafluorbenzensulfonamider og analoger
AU710173B2 (en) * 1996-07-19 1999-09-16 Tularik Inc. Pentafluorobenzenesulfonamides and analogs
AU747663B2 (en) * 1998-09-23 2002-05-16 Tularik Inc. Arylsulfonanilide ureas
WO2002039958A2 (en) * 2000-11-03 2002-05-23 Tularik Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
US20050250854A1 (en) * 2000-11-03 2005-11-10 Amgen Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
FR2834641B1 (fr) * 2002-01-14 2005-04-22 Ct Regional De Lutte Contre Le Protection de la neurotoxicite de l'oxaliplatine par administration de calcium et de magnesium
WO2005051303A2 (en) * 2003-11-19 2005-06-09 Lixin Zhang Screening for synergistic compounds
US10238831B2 (en) 2013-09-08 2019-03-26 Qool Therapeutics, Inc. Temperature measurement and feedback for therapeutic hypothermia
WO2016138045A1 (en) 2015-02-23 2016-09-01 Qool Therapeutics, Inc. Systems and methods for endotracheal delivery of frozen particles
WO2019046467A1 (en) 2017-08-29 2019-03-07 Rutgers, The State University Of New Jersey INDAZOLES THERAPEUTIC
US20200277268A1 (en) * 2017-09-21 2020-09-03 Dalriada Therapeutics Inc. Pentafluorophenyl sulfonamide compounds, compositions and uses thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1955207A (en) 1931-09-16 1934-04-17 Ig Farbenindustrie Ag Mothproofing agent
US2402623A (en) 1943-06-24 1946-06-25 Rohm & Haas Nu-nitroaryl haloarylsulphonamides
CH361275A (de) 1957-09-10 1962-04-15 Geigy Ag J R Verfahren zur Herstellung von neuen Arylsulfonarylamiden
GB1242057A (en) 1968-07-04 1971-08-11 Ici Ltd Derivatives of 4-hydroxytetrafluoropyridine and the use thereof as plant growth regulators
NL174644C (nl) 1970-04-13 1984-07-16 Minnesota Mining & Mfg Werkwijze ter bereiding van een herbicide verbinding; tevens werkwijze voor de bereiding van een preparaat met herbicide werking.
DE3623184A1 (de) 1986-07-10 1988-01-14 Kali Chemie Ag Verfahren zur herstellung von n-fluorsulfonamiden
US4883914A (en) 1987-08-17 1989-11-28 American Cyanamid Company Benzenesulfonyl carboxamide compounds useful as herbicidal agents
DE3804990A1 (de) 1988-02-18 1989-08-31 Basf Ag Herbizid wirksame, heterocyclisch substituierte sulfonamide
FR2645537B1 (fr) 1989-04-05 1994-03-04 Fabre Medicament Pierre Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique
FR2665440B1 (fr) 1990-07-31 1994-02-04 Lipha Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
US5189211A (en) 1990-08-01 1993-02-23 Taisho Pharmaceutical Co., Ltd. Sulfonamide derivatives
DE69129611T2 (de) 1990-08-20 1998-12-17 Eisai Co., Ltd., Tokio/Tokyo Sulfonamid-Derivate
WO1996040629A1 (en) 1995-06-07 1996-12-19 Sugen, Inc. Tyrphostin-like compounds for the treatment of cell proliferative disorders or cell differentiation disorders
DK0896533T3 (da) 1996-02-22 2004-01-26 Tularik Inc Pentafluorbenzensulfonamider og analoger
AU710173B2 (en) * 1996-07-19 1999-09-16 Tularik Inc. Pentafluorobenzenesulfonamides and analogs
ES2308068T3 (es) * 1996-10-15 2008-12-01 G.D. Searle Llc Uso de inhibidores de ciclooxigenasa-2 en el tratamiento y la prevencion de neoplasia.
CA2270469C (en) * 1996-11-19 2007-04-10 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
US5773236A (en) 1997-04-25 1998-06-30 Molecule Probes, Inc. Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules
JP2002518506A (ja) * 1998-06-25 2002-06-25 テュラリク インコーポレイテッド アリールスルホンアニリドホスフェート
AU747663B2 (en) * 1998-09-23 2002-05-16 Tularik Inc. Arylsulfonanilide ureas
AU2190700A (en) * 1998-12-17 2000-07-03 Tularik Inc. Tubulin-binding agents
CO5170498A1 (es) * 1999-05-28 2002-06-27 Abbott Lab Biaril sulfonamidas son utiles como inhibidores de proliferacion celular

Also Published As

Publication number Publication date
CN1367690A (zh) 2002-09-04
EP1206256A2 (en) 2002-05-22
CA2380078A1 (en) 2001-02-08
US6355628B1 (en) 2002-03-12
CA2380078C (en) 2008-05-06
AU6615200A (en) 2001-02-19
KR100685059B1 (ko) 2007-02-22
EP1206256B1 (en) 2005-05-04
IL147890A0 (en) 2002-08-14
JP2003505513A (ja) 2003-02-12
WO2001008693A3 (en) 2001-05-25
KR20020050225A (ko) 2002-06-26
CN1181819C (zh) 2004-12-29
RU2002105374A (ru) 2004-01-10
WO2001008693A2 (en) 2001-02-08
PT1206256E (pt) 2005-09-30
EP1206256B8 (en) 2005-06-29
AU775305B2 (en) 2004-07-29
IL147890A (en) 2007-07-04
ATE294574T1 (de) 2005-05-15
ES2241639T3 (es) 2005-11-01
ZA200200889B (en) 2003-03-26
DE60019937T2 (de) 2006-05-04
DE60019937D1 (de) 2005-06-09
RU2268054C2 (ru) 2006-01-20

Similar Documents

Publication Publication Date Title
ATE302775T1 (de) Carbolinderivate
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
ATE346067T1 (de) Carbolinderivate
CY1113054T1 (el) Παραγωγα διαμινης
IS7857A (is) Setnar pýrróló-pýrasól afleiður sem kínasa hindrar
DK1412317T3 (da) Retinoidderivater med antiangiogenetisk-, antitumor og pro-apoptotisk virkning
NO20035333D0 (no) Ny ligand for nikotiniske acetylkolinreseptorer som er nyttig i terapi
MXPA03002911A (es) Compuestos quimicos.
DK1206256T3 (da) Kombinationsbehandling under anvendelse af pentafluorbenzensulfonamid og platinforbindelse
MXPA02012076A (es) Compuestos quimicos.
MXPA02012659A (es) Derivados de pirazindiona condensados.
ATE386742T1 (de) Imidazonaphthyridine
ATE297904T1 (de) Halo-alkoxycarbonylverbindungen
DK1313740T3 (da) Prodrugs af imidazopyridinderivater
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
TR199902257T2 (xx) Tetrahidropirido bile�ikleri
DK1383742T3 (da) Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
SE0301650D0 (sv) Novel compounds
DK1379508T3 (da) N-(aryl)-2arylethensulfonamider og terapeutiske anvendelser deraf
DE60112960D1 (de) Kondensierte pyridoindolderivate
DE60127131D1 (de) Tricyclische imidazopyridine
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
MXPA05006957A (es) Nuevos derivados de fosforamida.